Back to search
FDAFDA · Food and drugs·Recall number D-0201-2024

Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1721-01

Published January 3, 2024 · Recall initiated: January 26, 2022

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
WARFARIN SODIUM
Manufacturer
CARDINAL HEALTHCARE
Distributor
Nationwide USA
UPC
0300931721013
Lot
Batch 2323041
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card